About
Chloe Jennett serves as an Adjunct Associate Lecturer at the Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney. Her academic work focuses on cancer prevention and screening programs, particularly in the area of cervical cancer and HPV-related research.
Dr. Jennett's research interests center on cervical cancer screening implementation, HPV testing methodologies, and public health approaches to cancer prevention. Her work examines the practical challenges of implementing new screening technologies within healthcare systems, including the impact of the COVID-19 pandemic on screening attendance and the introduction of self-collection methods for HPV testing. She has conducted significant research on the psychosocial aspects of cancer screening programs, investigating how screening participation affects patient psychology and quality of life.
Analysis of Dr. Jennett's publication record reveals a consistent focus on cervical cancer screening program evaluation, with particular emphasis on the implementation of primary HPV testing in Australia. Her research spans epidemiological studies, qualitative investigations of stakeholder perspectives, and systematic reviews of psychosocial impacts. The work demonstrates interdisciplinary collaboration across public health, oncology, and psychology domains, with strong connections to national cancer control initiatives.
Dr. Jennett has been actively involved in the Compass study, a major Australian research initiative examining cervical screening approaches. Her collaborative work spans multiple institutions and has contributed significantly to the evidence base supporting Australia's transition to primary HPV screening. While specific grant details aren't provided in the available information, her publication record indicates substantial involvement in nationally significant cancer prevention research initiatives.